Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20250601066005N1Phase 3Completed
Phase 3, randomised trial in postoperative pain comparing Preemptive ketorolac, Preemptive pregabalin and Preemptive ketorolac + pregabalin (3 arms). Primary endpoint: Postoperative pain intensity. Started Oct 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20250601066005N1.